Case Study: Johanna Koen's Journey with Lupus

Picture: News24 

Case Background

Johanna, a long-term lupus patient of over 20 years, struggled with chronic inflammation, pain, and joint degeneration. Despite requiring hip and knee replacements, she began KineDek AI-CRT sessions in early 2022, attending twice-weekly 20-minute sessions on most weeks. This continued until November 2023, after which she took a break. In May 2024, she resumed weekly sessions following a flu-related relapse.

Analysis

1. Improved Organ Function and Inflammation Management

Lupus frequently causes systemic inflammation and organ damage, including kidney involvement. After four months of KineDek sessions, pathology tests in June 2022 revealed improved kidney function and normalized inflammation markers compared to a test from the prior year. This suggests KineDek’s anti-inflammatory effects may have contributed to these improvements. By engaging muscles through adaptive resistance, KineDek likely facilitated the release of myokines, improved circulation, and enhanced cellular repair—all critical factors in reducing inflammation and supporting kidney health.

2. Reduced Dependency on Medications

Consistent KineDek sessions enabled Johanna to significantly reduce her reliance on pain and anti-inflammatory medications. From November 2023 to April 2024, she maintained normal energy levels and a pain-free status without requiring these drugs. This underscores KineDek’s role in breaking the cycle of inflammation and pain while supporting long-term recovery.

3. Sustained Benefits Amid Challenges

Following a break from KineDek and contracting the flu in April 2024, Johanna experienced prolonged post-exercise malaise and a partial relapse of symptoms. However, resuming weekly KineDek sessions in May 2024 quickly restored her health. She once again became medication-free, demonstrating KineDek’s ability to re-establish systemic balance and support recovery during health setbacks.

4. Joint Health and Functional Comfort

Despite requiring hip and knee replacements, Johanna experienced lasting comfort in these joints. No further strain or indication of replacement needs has arisen, suggesting that KineDek contributed to joint stability and overall musculoskeletal health.

Conclusion

This case highlights KineDek AI-CRT’s transformative potential for managing lupus, an autoimmune condition with complex systemic effects. Through its soft-action, AI-driven resistance technology, KineDek enabled sustained symptom relief, improved organ function, and reduced reliance on medications. Even during a relapse, the rapid restoration of health upon resuming sessions reinforces its efficacy as a long-term therapeutic tool. Johanna’s experience exemplifies how KineDek can redefine recovery pathways for individuals with chronic autoimmune conditions, offering hope for sustained health and functionality. 

Disclaimer: 

The above has been feedback from the personal experiences of an individual who have used the KineDek. These accounts are individual to each person and are not to be taken as a guarantee that others will experience the same outcomes. The KineDek is not presented as a cure for any condition. Rather, it serves as an enabler for exercise, particularly for those who may otherwise find traditional forms of exercise challenging or painful. Through its AI-enabled Compensating Resistance Technology (AI-CRT), the KineDek allows individuals to engage in physical activity without perceived pain, strain, or subsequent inflammation. Consequently, users can enjoy the well-documented benefits of "Exercise as Medicine." If you have a serious medical condition, always consult with a healthcare professional before starting any new exercise regimen. 

All cases presented can be verified on request. 

KINEDEK CASES

Popular Posts